Item 2.02. Results of Operations and Financial Condition.

On August 6, 2012, Cleveland BioLabs, Inc. issued a press release announcing its second quarter 2012 financial results. The information in this Form 8-K and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibit No. Description
99.1 Press Release dated August 6, 2012

---